|
⚲
|
| Keyboard |
| Instil Bio Inc | |
|---|---|
| Ticker | TIL |
| CIK # | 0001789769 |
| CUSIP | 45783C200 |
| Sector | Life Sciences - Biological Products, (No Disgnostic Substances) |
| Address | 3963 Maple Avenue Suite 350, Dallas, TX 75219 |
| Source | [EDGAR] |
| Reg D Offering (Form D) | Filed | Raised | Terms |
|---|---|---|---|
| Instil Bio Inc | 2021-02-23 | 185.4 M | Exemption: 506(b) · Duration: One year or less · Revenue: Decline to Disclose |
| CIK | Filing | 2011 - 2026 |
|---|---|---|
| [0001789769] | 10-K | |
| [0001789769] | 10-Q | |
| [0001789769] | 3 | |
| [0001789769] | 4 | |
| [0001789769] | 8-K | |
| [0001789769] | D | |
| [0001789769] | SC 13D | |
| [0001789769] | SC 13G |
| Form 13D/13G Filer | Form 13D/13G Subject | Filed | % Owned |
|---|---|---|---|
| Boxer Capital LLC | Instil Bio Inc | [2024-09-27] | 5.5 |
| Perceptive Advisors LLC | Instil Bio Inc | [2024-09-27] | 81945.3 |
| BML Investment Partners LP | Instil Bio Inc | [2024-04-02] | 5.3 |
| RA Capital Management LP | Instil Bio Inc | [2022-06-22] | 5.93 |
| FMR LLC | Instil Bio Inc | [2021-11-10] | 0.0 |
| Venrock Healthcare Capital Partners II LP | Instil Bio Inc | [2021-04-15] | 5.4 |
| Curative Ventures V LLC | Instil Bio Inc | [2021-04-05] | 29.6 |
| CPMG Inc | Instil Bio Inc | [2021-04-01] | 6.6 |
| Vivo Capital IX LLC | Instil Bio Inc | [2021-04-01] | 0.7 |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Common Stock
|
2025-09-10 | Option exercise | 17,000 | $11.60 | 197,200 |
|
Common Stock
|
2025-09-10 | Sell | 17,539 | $23.04 | 404,099 |
|
Employee Stock Option (right to buy) · derivative
|
2025-09-10 | Option exercise | 13,000 | $0.00 | |
|
Common Stock
|
2025-09-10 | Option exercise | 13,000 | $12.68 | 164,840 |
|
Employee Stock Option (right to buy) · derivative
|
2025-09-10 | Option exercise | 17,000 | $0.00 | |
|
Common Stock
|
2025-09-10 | Sell | 12,461 | $23.88 | 297,569 |
|
Gibson Neil W
Stock Option (Right to Buy) · derivative
|
2025-05-28 | Grant | 6,500 | $0.00 | |
|
Matcham George
Stock Option (Right to Buy) · derivative
|
2025-05-28 | Grant | 6,500 | $0.00 | |
|
McGaughy R Kent Jr
Stock Option (Right to Buy) · derivative
|
2025-05-28 | Grant | 6,500 | $0.00 | |
|
Binder Gwendolyn
Stock Option (Right to Buy) · derivative
|
2025-05-28 | Grant | 6,500 | $0.00 | |
|
Crouch Bronson
Employee Stock Option (right to buy) · derivative
|
2025-04-25 | Grant | 105,157 | $0.00 | |
|
Laumas Sandeep
Employee Stock Option (right to buy) · derivative
|
2025-04-25 | Grant | 44,851 | $0.00 | |
|
Laumas Sandeep
Employee Stock Option (right to buy) · derivative
|
2024-09-18 | Grant | 45,000 | $0.00 | |
|
Crouch Bronson
Employee Stock Option (right to buy) · derivative
|
2024-09-18 | Grant | 50,000 | $0.00 | |
|
Matcham George
Stock Option (Right to Buy) · derivative
|
2024-06-13 | Grant | 5,000 | $0.00 | |
|
Binder Gwendolyn
Stock Option (Right to Buy) · derivative
|
2024-06-13 | Grant | 5,000 | $0.00 | |
|
McGaughy R Kent Jr
Stock Option (Right to Buy) · derivative
|
2024-06-13 | Grant | 5,000 | $0.00 | |
|
Gibson Neil W
Stock Option (Right to Buy) · derivative
|
2024-06-13 | Grant | 5,000 | $0.00 | |
|
Crouch Bronson
Employee Stock Option (right to buy) · derivative
|
2024-02-10 | Grant | 120,000 | $0.00 | |
|
Laumas Sandeep
Employee Stock Option (right to buy) · derivative
|
2024-02-10 | Grant | 80,000 | $0.00 | |
| showing 20 of 104 most recent transactions | |||||
| 13F Ownership Over Time | Holders | Shares Held |
|---|---|---|
| 2026-03-31 | 32 | 4,326,467 |
| 2025-12-31 | 29 | 4,442,809 |
| 2025-09-30 | 34 | 4,554,273 |
| 2025-06-30 | 39 | 4,650,605 |
| 2025-03-31 | 44 | 5,252,466 |
| 2024-12-31 | 41 | 5,238,379 |
| 2024-09-30 | 50 | 5,309,847 |
| 2024-06-30 | 31 | 4,354,942 |
| 2024-03-31 | 32 | 4,258,750 |
| 2023-12-31 | 31 | 4,068,678 |
| 2023-09-30 | 59 | 80,281,162 |
| 2023-06-30 | 63 | 82,160,773 |
| Form 13F Holdings | ||||
|---|---|---|---|---|
| Firm | Period | DFND | Voting | Shares | Prev | Page 1 | Next |